Literature DB >> 28326130

Getting to 90-90-90 in paediatric HIV: What is needed?

Mary-Ann Davies, Jorge Pinto, Marlène Bras.   

Abstract

Entities:  

Keywords:  90-90-90 target; AIDS; ART; HIV; HIV comorbidities; HIV drug resistance; HIV prevention; HIV/AIDS; PITC; SMS; adherence; adolescents; antiretroviral adherence; antiretroviral therapy; antiretroviral treatment; antiretrovirals; child survival; children; development; diagnosis; double dividend; epidemiology; formulations; guidelines; infant; integration; low birth weight; low- and middle-income countries; management; maternal-child health; non-nucleoside reverse transcriptase inhibitor; optimization; paediatric HIV; perinatal HIV infection; point of care; premature; prevention of mother-to-child HIV transmission; protease inhibitor; psychological complications; small for gestation; social protection; transition; treatment; tuberculosis

Year:  2015        PMID： 28326130      PMCID： PMC4813611          DOI： 10.7448/IAS.18.7.20770

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN： 1758-2652            Impact factor:   5.396


× No keyword cloud information.
  688 in total

1.  Trends in transition from pediatric to adult health care services for young adults with chronic conditions.

Authors:  P Scal; T Evans; S Blozis; N Okinow; R Blum
Journal:  J Adolesc Health       Date:  1999-04       Impact factor: 5.012

2.  Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals.

Authors:  F E Babl; A M Regan; S I Pelton
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

3.  HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

Authors:  A R Zolopa; R W Shafer; A Warford; J G Montoya; P Hsu; D Katzenstein; T C Merigan; B Efron
Journal:  Ann Intern Med       Date:  1999-12-07       Impact factor: 25.391

4.  Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Authors:  P Lorenzi; M Opravil; B Hirschel; J P Chave; H J Furrer; H Sax; T V Perneger; L Perrin; L Kaiser; S Yerly
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

5.  Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.

Authors:  A Vernon; W Burman; D Benator; A Khan; L Bozeman
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

6.  Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium.

Authors:  P Thomas; K Bornschlegel; T P Singh; E J Abrams; J Cervia; S Fikrig; G Lambert; H Mendez; K Kaye; J Bertolli
Journal:  Pediatr Infect Dis J       Date:  2000-08       Impact factor: 2.129

7.  Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children.

Authors:  S M Graham; A L Walsh; E M Molyneux; A J Phiri; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

8.  Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Authors:  A B Moscicki; J H Ellenberg; S H Vermund; C A Holland; T Darragh; P A Crowley-Nowick; L Levin; C M Wilson
Journal:  Arch Pediatr Adolesc Med       Date:  2000-02

9.  HIV-1 co-infection in children hospitalised with tuberculosis in South Africa.

Authors:  S A Madhi; R E Huebner; L Doedens; T Aduc; D Wesley; P A Cooper
Journal:  Int J Tuberc Lung Dis       Date:  2000-05       Impact factor: 2.373

Review 10.  Organ-specific manifestations of HIV disease in children.

Authors:  O R Abuzaitoun; I C Hanson
Journal:  Pediatr Clin North Am       Date:  2000-02       Impact factor: 3.278
View more
  9 in total

1.  Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.

Authors: 
Journal:  Lancet HIV       Date:  2019-02       Impact factor: 12.767

2.  Evidence-based service delivery interventions for testing, linking, treating, and retaining children and adolescents living with HIV in primary health care settings: Protocol for a systematic review.

Authors:  Nande Putta; Caitlin E Hansen; Melissa C Funaro; Melissa Campbell; Shaffiq Essajee; Dorothy Mbori-Ngacha; Shadrack Frimpong; Shi-Yi Wang; Elijah Paintsil
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

3.  An open-source molecular diagnostic platform approach for outbreak and epidemic preparedness.

Authors:  Devy M Emperador; Laura T Mazzola; Cassandra Kelly-Cirino
Journal:  Afr J Lab Med       Date:  2020-09-28

4.  Challenges and opportunities of optimal breastfeeding in the context of HIV option B+ guidelines.

Authors:  Pamela Marinda; Nkandu Chibwe; Ernest Tambo; Sidney Lulanga; Christopher Khayeka-Wandabwa
Journal:  BMC Public Health       Date:  2017-06-02       Impact factor: 3.295

5.  Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda.

Authors:  Esther Nasuuna; Joanita Kigozi; Lillian Babirye; Alex Muganzi; Nelson K Sewankambo; Damalie Nakanjako
Journal:  BMC Public Health       Date:  2018-08-22       Impact factor: 3.295

6.  Traversing the cascade: urgent research priorities for implementing the 'treat all' strategy for children and adolescents living with HIV in sub-Saharan Africa.

Authors:  Leslie A Enane; Mary-Ann Davies; Valériane Leroy; Andrew Edmonds; Edith Apondi; Adebola Adedimeji; Rachel C Vreeman
Journal:  J Virus Erad       Date:  2018-11-15

7.  Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon.

Authors:  Anne Esther Njom Nlend; Cathya Ornella Guessong; Annie Carole Nga Motaze; Claudian Soffo; Paul Olivier Koki Ndombo; Lionel Tsambang; Joseph Fokam
Journal:  PLoS One       Date:  2019-03-18       Impact factor: 3.240

8.  Equity of child and adolescent treatment, continuity of care and mortality, according to age and gender among enrollees in a large HIV programme in Tanzania.

Authors:  Sumona Chaudhury; Ellen Hertzmark; Aisa Muya; David Sando; Nzovu Ulenga; Lameck Machumi; Donna Spiegelman; Wafaie W Fawzi
Journal:  J Int AIDS Soc       Date:  2018-02       Impact factor: 5.396

9.  Perceived Barriers Toward Provider-Initiated HIV Testing and Counseling (PITC) in Pediatric Clinics: A Qualitative Study Involving Two Regional Hospitals in Dar-Es-Salaam, Tanzania.

Authors:  Rose Marwa; Amani Anaeli
Journal:  HIV AIDS (Auckl)       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.